Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With Fluvoxamine

Recurrent Depressive Disorder Clinical Trial

Official title:
Open Label, Non-comparative Study to Evaluate Cognitive Functioning in Remitted Depression Outpatients During Long-term Preventive Treatment With Fluvoxamine

Status Completed

Clinical Trial Summary

Open label, non-comparative, prospective study to evaluate cognitive functioning in remitted depression outpatients during long-term preventive treatment with Fluvoxamine (Fevarin®)

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02016261
Study type	Interventional
Source	Moscow Research Institute of Psychiatry
Contact
Status	Completed
Phase	Phase 4
Start date	December 2013
Completion date	July 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01722344` - Improving Work Outcome for People With Severe Mental Illness	N/A
Completed	`NCT04239521` - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Completed	`NCT01973478` - Deep Brain Stimulation in Patients With Chronic Treatment Resistant Depression	N/A
Completed	`NCT04953338` - Mental Health Associations With Vitiligo
Completed	`NCT05206734` - Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health
Terminated	`NCT02661061` - Ketamine for Relapse Prevention in Recurrent Depressive Disorder	Phase 1
Recruiting	`NCT05641623` - OSU6162 as add-on in SSRI/SNRI-resistant Depression	Phase 2